外膜脂肪生成性退化是腹主动脉瘤壁薄弱的一个未被识别的因素
该转化研究通过组织学、分子生物学及细胞实验比较腹主动脉瘤(AAA)、腘动脉瘤(PAA)与对照主动脉,发现AAA外膜脂肪细胞聚集为独有现象(P < .001),脂肪生成介质富集且AAA外膜间充质细胞成脂潜力显著增加(P < .0001),破裂AAA中脂肪相关基因富集(P < .0003),提示脂肪退化程度与破裂相关。
要点
- AAA外膜脂肪细胞聚集是AAA独有现象,与PAA和对照主动脉不同。
- AAA组织中脂肪生成介质(C/EBP家族、KLF5、PPAR-γ)表达富集。
- 破裂AAA中脂肪细胞相关基因和通路富集,提示脂肪退化与破裂相关。
核心结论
- 外膜广泛脂肪退化是AAA疾病一个被忽视且独特的特征。
- 破裂AAA中脂肪细胞生成及相关基因富集提示脂肪退化程度与破裂相关。
- 该观察可能部分解释药物治疗失败,并为药物治疗缓解AAA进展提供线索。
研究设计与样本
- 转化研究,收集开放择期和急诊修复的动脉瘤壁样本。
- 对照肾周主动脉来自肾移植,参考腘动脉组织来自解剖部门。
- 采用(免疫)组织化学、Western Blot、定量聚合酶链反应、微阵列和细胞培养等技术。
主要发现
- 组织学评估显示AAA透壁纤维化、PAA中膜纤维化,AAA外膜脂肪细胞聚集为独有现象(P < .001)。
- 定量PCR、免疫组化、Western blot和微阵列分析显示AAA组织中脂肪生成介质富集:C/EBP家族P = .027;KLF5 P < .000;PPAR-γ P = .032。
- 体外分化试验表明AAA外膜间充质细胞成脂潜力急剧增加(P < .0001)。
- 破裂AAA中脂肪细胞相关基因和通路富集(P < .0003)。
临床怎么用
- 外膜脂肪退化可作为AAA壁薄弱的潜在生物标志物或治疗靶点。
- 未来药物开发可考虑针对脂肪生成过程以减缓AAA进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The processes driving human abdominal aortic aneurysm (AAA) progression are not fully understood. Although antiinflammatory and proteolytic strategies effectively quench aneurysm progression in preclinical models, so far all clinical interventions failed. These observations hint at an incomplete understanding of the processes involved in AAA progression and rupture. Interestingly, strong clinical and molecular associations exist between popliteal artery aneurysms (PAAs) and AAAs; however, PAAs have an extremely low propensity to rupture. We thus reasoned that differences between these aneurysms may provide clues toward (auxiliary) processes involved in AAA-related wall debilitation. A better understanding of the pathophysiologic processes driving AAA growth can contribute to pharmaceutical treatments in the future. METHODS: Aneurysmal wall samples were collected during open elective and emergency repair. Control perirenal aorta was obtained during kidney transplantation, and reference popliteal tissue obtained from the anatomy department. This study incorporates various techniques including (immuno)histochemistry, Western Blot, quantitative polymerase chain reaction, microarray, and cell culture. RESULTS: Histologic evaluation of AAAs, PAAs, and control aorta shows extensive medial (PAA) and transmural fibrosis (AAA), and reveals abundant adventitial adipocytes aggregates as an exclusive phenomenon of AAAs (P < .001). Quantitative polymerase chain reaction, immunohistochemistry, Western blotting, and microarray analysis showed enrichment of adipogenic mediators (C/EBP family P = .027; KLF5 P < .000; and peroxisome proliferator activated receptor-γ, P = .032) in AAA tissue. In vitro differentiation tests indicated a sharply increased adipogenic potential of AAA adventitial mesenchymal cells (P < .0001). Observed enrichment of adipocyte-related genes and pathways in ruptured AAA (P < .0003) supports an association between the extent of fatty degeneration and rupture. CONCLUSIONS: This translational study identifies extensive adventitial fatty degeneration as an ignored and distinctive feature of AAA disease. Enrichment of adipocyte genesis and adipocyte-related genes in ruptured AAA point to an association between the extent of fatty degeneration and rupture. This observation may (partly) explain the failure of medical therapy and could provide a lead for pharmaceutical alleviation of AAA progression.
引用
- Doderer SA, Gäbel G, Kokje VBC, et al. Adventitial adipogenic degeneration is an unidentified contributor to aortic wall weakening in the abdominal aortic aneurysm. J Vasc Surg. 2017. PMID: 28912007. doi:10.1016/j.jvs.2017.05.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。